Precocious hypothyroidism mechanisms after radioiodine treatment in Graves’ disease

Cooper, 2005, Treatment for thyrotoxicosis, 665

Sawers, 1980, Transient hypothyroidism after iodine-131 treatment of thyrotoxicosis, J Clin Endocrinol Metabol, 50, 226, 10.1210/jcem-50-2-226

Aizawa, 1997, The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves’ disease: prevalence, mechanism and prognosis, Clin Endocrinol, 46, 1, 10.1046/j.1365-2265.1997.d01-1737.x

Chiovato, 1998, Outcome of thyroid function in Graves’ patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage, J Clin Endocrinol Metabol, 83, 40, 10.1210/jc.83.1.40

DeGroot, 1997, Radioiodine and the immune system, Thyroidology, 7, 259, 10.1089/thy.1997.7.259

Connell, 1983, Transient hypothyroidism following radioiodine therapy for thyrotoxicosis, Br J Radiol, 56, 309, 10.1259/0007-1285-56-665-309

Michelangeli, 1995, Specific effects of radioiodine treatment on TSAb et TBAb levels in patients with Grave's disease, Thyroidology, 5, 171, 10.1089/thy.1995.5.171

Yoshida, 1998, Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves’ disease, Clin Endocrinol, 48, 17, 10.1046/j.1365-2265.1998.00330.x

Kung, 2000, Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy, Thyroidology, 10, 909, 10.1089/thy.2000.10.909

Bartanela, 1998, Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy, New Engl J Med, 338, 73, 10.1056/NEJM199801083380201

Costagliola, 1992, Binding assay for thyrotropin receptor antibodies using the recombinant receptor protein, J Clin Endocrinol Metabol, 75, 1540, 10.1210/jc.75.6.1540

Teng, 1980, A prospective study of the changes in thyrotropin binding inhibitory immunoglobulins in Graves’ disease treated by subtotal thyroidectomy or radioactive iodine, J Clin Endocrinol Metabol, 50, 1005, 10.1210/jcem-50-6-1005

Bech, 1982, Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves’ disease after radioiodine administration, Clin Endocrinol, 17, 395, 10.1111/j.1365-2265.1982.tb01605.x

Atkinson, 1982, Effect on stimulatory activity of Grave's immunoglobulins, Clin Endocrinol, 16, 537, 10.1111/j.1365-2265.1982.tb03170.x

McGregor, 1979, Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves’ disease, Clin Endocrinol, 11, 437, 10.1111/j.1365-2265.1979.tb03095.x

Andrade, 2004, Serum thyrotropin-receptor autoantibodies levels after 131I therapy in Graves’ patients: effects of pretreatment with methimazole evaluated by a prospective, randomized study, Eur J Endocrinol, 151, 467, 10.1530/eje.0.1510467

Béné, 2001, Mécanismes généraux de l’immunité cellulaire et humorale, 216

Jensen, 2005, Glucocorticoids do not influence the effect of radioiodine therapy in Graves’ disease, Eur J Endocrinol, 153, 15, 10.1530/eje.1.01924

Noh, 2000, Thyroid stimulating antibody is related to Graves’ ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves’ disease, Thyroid, 10, 809, 10.1089/thy.2000.10.809

Eckstein, 2004, Clinical results of anti-inflammatory therapy in Graves’ ophthalmopathy and association with thyroidal autoantibodies, Clin Endocinol (Oxford), 61, 612, 10.1111/j.1365-2265.2004.02143.x